Gncc Capital Inc. logo

Gncc Capital Inc. (GNCP)

Market Closed
8 Dec, 14:31
OTC PINK OTC PINK
OTC PINK OTC PINK Primary
$
0. 00
0
0%
$
17.41M Market Cap
- P/E Ratio
0% Div Yield
0 Volume
0 Eps
$ 0
Previous Close
Day Range
0 0
Year Range
0 0
Want to track GNCP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free

Summary

GNCP closed Monday higher at $0, an increase of 0% from Friday's close, completing a monthly increase of 0% or $0. Over the past 12 months, GNCP stock lost -50%.
GNCP is not paying dividends to its shareholders.
The last earnings report, released on Jun 30, 2015, missed the consensus estimates by 0%. On average, the company has fell short of earnings expectations by 0%, based on the last three reports.
Gncc Capital Inc. has completed 2 stock splits, with the recent split occurring on Dec 01, 2008.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

GNCP Chart

No Data

Gncc Capital Inc. (GNCP) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Gncc Capital Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is GNCP.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 17.41M.

Has Gncc Capital Inc. ever had a stock split?

Gncc Capital Inc. had 2 splits and the recent split was on Dec 01, 2008.

Gncc Capital Inc. Profile

Metals & Mining Industry
Materials Sector
Mr. Nicolaas Edward Blom CEO
OTC PINK Exchange
38013E203 CUSIP
US Country
- Employees
- Last Dividend
1 Dec 2008 Last Split
- IPO Date

Overview

GNCC Capital, Inc. is a company that operates through its subsidiary, BioCann Pharma S.A.S., focusing on the production and sale of cannabis CBD pharmaceutical-grade oils. The company's base of operations is in Las Vegas, Nevada, from where it manages its production processes and distribution strategies. GNCC Capital, Inc. has positioned itself within the cannabis industry by targeting the Latin American market, leveraging Colombia's progressive stance on cannabis cultivation and processing. By doing so, it aims to capture a significant share of the pharmaceutical-grade CBD oil market in the region.

Products and Services

  • Cannabis CBD Pharmaceutical Grade Oils

    GNCC Capital, Inc., through its subsidiary, BioCann Pharma S.A.S., produces premium cannabis CBD oils that meet pharmaceutical grade standards. These oils are designed for various therapeutic applications, catering to a growing demand for high-grade CBD products in the healthcare and wellness sectors. The careful extraction and purification process ensures that each product contains a consistent and potent dosage of CBD, making it suitable for medical use under appropriate legal and regulatory frameworks.

  • Distribution Channels in Colombia and Latin America

    The company has established a solid distribution network that spans Colombia and extends throughout Latin America. This strategic distribution allows GNCC Capital, Inc. to effectively reach its target markets, including pharmacies, healthcare providers, and specialty retailers who cater to consumers seeking pharmaceutical-grade CBD products. The expansive distribution strategy is instrumental in ensuring product availability across a vast geographic area, facilitating access to high-quality CBD oils for a wide range of consumers.

Contact Information

Address: 848 North Rainbow Boulevard
Phone: 702 990 0156
Affiliate Program About Terms Privacy Help Contact Us
2025 © Marketlog. All Rights Reserved.
Play store app banner Play store app banner dark App store app banner App store app banner dark